21 May 2018
The IPC has had Observer status since 2016 and has participated in Ph. Eur. Commission working groups. The symposium was attended by authorities and manufacturers of APIs.
An overview of reference standards policies and processes was presented as well as advice on how to interpret European Pharmacopoeia general chapters and monographs. To address the complex nature of global API sourcing, EDQM’s Procedure for Certification of Suitability (CEP), which offers industry and regulators a centralized procedure for accessing highly regulated markets, was discussed.
“The collaboration between the two Pharmacopoeias shows the commitment on both sides in making the best scientific resources available for the protection of health in India, in Europe and the rest of the world,” stated Susanne Keitel, PhD, director of EDQM, in a press release. “In today’s globalised pharmaceutical industry with complex supply chains, new risks and challenges, the cooperation and interaction with its Observers is crucial for the Ph. Eur. With the Indian pharmaceutical industry leading in the provision of high quality generics to the world, IPC is one of our most prominent partners,” Keitel said.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The overall mortality rate of the population in Russia decreased by 7% in 2023
28 March 2024
Russia to collaborate with Hungary and Serbia in nuclear medicine
28 March 2024
Researchers propose novel test for pyrogen detection
27 March 2024
Parkinson’s infusion treatment demonstrates advantage over oral delivery
27 March 2024